U.S. Mortgage Finance Stock News

NYSE:GNK
NYSE:GNKShipping

Genco Shipping Proxy Battle Puts Board Control And Valuation In Focus

Genco Shipping & Trading (NYSE:GNK) is in an escalating proxy contest with its largest shareholder, Diana Shipping Inc. Diana is seeking to replace Genco’s board and gain control of the company, while Genco’s directors oppose the effort. Independent proxy advisory firms Glass Lewis & Co. and Egan-Jones have publicly recommended that shareholders support Genco’s current board ahead of the June 18, 2026 annual meeting. For investors watching NYSE:GNK, this governance fight comes after a...
NYSE:AM
NYSE:AMOil and Gas

Antero Midstream Acquisition Reshapes Scale EBITDA Growth And Risk Profile

Antero Midstream (NYSE:AM) has completed its largest acquisition ahead of schedule. The company is working to integrate the acquired assets, with a focus on water system integration by year-end. Management is targeting high single digit EBITDA growth and greater financial flexibility following the transaction. Antero Midstream operates midstream infrastructure that supports energy production, including gathering, compression, and water services. For investors watching the midstream space,...
NYSE:DDS
NYSE:DDSMultiline Retail

Dillard's Restructuring Approval Raises Questions On Control And Valuation

Shareholders of Dillard's (NYSE:DDS) have approved a corporate restructuring that includes a merger with W.D. Company, Inc. The vote also supports the issuance of new Class A and Class B shares as part of the transaction. This approval clears the way for changes to Dillard's capital structure and corporate governance framework. Dillard's operates a broad network of department stores, with a focus on apparel, cosmetics, and home goods. The sector has been reshaped by e-commerce, changing...
OTCPK:NLST
OTCPK:NLSTElectronic

Assessing Netlist (OTCPK:NLST) Valuation After AI Data Center Demand And SK Hynix Contract Dependence

Why Netlist’s Growth Drivers Are Getting So Much Attention Netlist (NLST) is drawing fresh attention after rapid revenue growth tied to AI data center demand, tight memory supply, and large resale volumes from SK Hynix put its supplier and contract exposure in focus. See our latest analysis for Netlist. At a share price of $2.91, Netlist has pulled back around 7% over the past day and 5% over the past week, yet retains a 90 day share price return of about 139% and a year to date share price...
NasdaqGS:GIII
NasdaqGS:GIIILuxury

G III Apparel Group (GIII) Margin Compression Challenges Bullish Earnings Narratives

G-III Apparel Group (GIII) opened fiscal 2027 with Q1 revenue of US$535.9 million and basic EPS of US$1.58, presenting a very different earnings profile compared with the more mixed quarters that ran through fiscal 2026. Over the last six reported periods, revenue has moved between US$535.9 million and US$988.6 million while quarterly basic EPS has ranged from a loss of US$0.76 to a profit of US$1.91, giving you a wide view of how the earnings engine has behaved across different seasons...
NasdaqGS:SHOE
NasdaqGS:SHOESpecialty Retail

Shoe Carnival (SCVL) Quarterly Loss And Margin Compression Reinforce Bearish Profitability Narratives

Shoe Carnival (SCVL) opened Q1 2027 with revenue of US$270.7 million and a loss per share of US$0.21, as net income moved to a loss of US$5.6 million for the quarter. Over the past year, the company has seen trailing twelve month revenue at about US$1.13 billion and EPS of US$1.36, compared with trailing revenue of US$1.20 billion and EPS of US$2.72 back in Q4 2025, setting a clear context for how the latest quarter fits into a longer earnings reset. For investors, the shift from quarterly...
NYSE:HUM
NYSE:HUMHealthcare

Is Humana’s (HUM) Orlando Pharmacy Bet Quietly Redefining Its Efficiency Story?

In May 2026, Humana’s CenterWell Pharmacy began full operations at an US$83 million, 162,000-square-foot mail-order distribution center in Orlando, Florida, capable of handling up to 64,000 prescriptions per day and employing more than 165 specialists. The new Orlando facility expands CenterWell Pharmacy’s national fulfillment network, supporting payer-agnostic partnerships and free pharmacy technician training that could deepen Humana’s role in medication access and workforce development...
NasdaqGS:KYIV
NasdaqGS:KYIVWireless Telecom

A Look At Kyivstar Group (NasdaqGS:KYIV) Valuation As Shares Show Recent Mixed Returns

Kyivstar Group stock reaction Kyivstar Group (KYIV) has drawn fresh attention after recent trading left the stock at US$13.73, with returns mixed, down 1.5% over the past day but up over the past month and past 3 months. See our latest analysis for Kyivstar Group. That mixed daily and weekly picture sits alongside a 30 day share price return of 8.0%, a 90 day share price return of 15.6% and a 1 year total shareholder return of 20.9%. Recent momentum therefore appears to be building from a...
NasdaqGS:SATS
NasdaqGS:SATSMedia

Is It Too Late To Consider EchoStar (SATS) After Last Week’s Share Price Pullback?

Wondering if EchoStar at around US$116 per share still offers value, or if most of the upside is already behind it? This article focuses on what the current price really implies. The stock is up a very large amount over the past year. However, it is up 3.7% year to date and has fallen 10% over the past week and 7.5% over the past month. These moves can change how you think about risk and potential entry points. Recent coverage has focused on EchoStar’s sharp share price gains and what they...
NasdaqGS:COO
NasdaqGS:COOMedical Equipment

Cooper Companies (COO) Margin Hit And Q2 Loss Challenge Bullish Earnings Narratives

Cooper Companies (COO) has put mixed numbers on the table for Q2 2026, with revenue at US$1.1 billion, a reported loss of US$77.9 million and basic EPS of US$0.40 loss, setting a very different tone from the prior few quarters of positive earnings. Over the past six quarters, revenue has moved from US$964.7 million in Q1 2025 to US$1.1 billion in Q2 2026. Basic EPS has ranged from US$0.52 in Q1 2025 to US$0.67 in Q1 2026 before flipping to a loss this quarter, leaving investors focused...
NasdaqGS:SIGI
NasdaqGS:SIGIInsurance

Slowing Growth And Margin Pressure Might Change The Case For Investing In Selective Insurance Group (SIGI)

Recently released analysis shows that Selective Insurance Group has seen demand cool, with estimated 12‑month sales growth of just 1.7% alongside higher operating expenses and a 3.2 percentage point contraction in pre‑tax profit margins. Despite earnings per share growing 12.6% annually over the past two years, the stock’s 1.4x forward price‑to‑book multiple suggests investors remain cautious about the insurer’s current fundamentals. We’ll now explore how slowing demand and rising expenses...
NasdaqGS:LULU
NasdaqGS:LULULuxury

Lululemon Athletica (LULU) Margin Compression In Q1 2027 Challenges Bullish Growth Narratives

Lululemon Athletica (LULU) opened fiscal Q1 2027 with total revenue of US$2.5b and basic EPS of US$1.70, alongside net income of US$195.0m, setting the tone for how the new year is starting after a busy 2026. The company has seen quarterly revenue move from US$2.4b and EPS of US$2.61 in Q1 2026 to US$2.5b and EPS of US$1.70 in Q1 2027, with trailing twelve month revenue at US$11.2b and EPS at US$12.76, which gives a fuller sense of scale. For investors, the focus now is on how these results...
NasdaqGM:KDK
NasdaqGM:KDKAuto Components

A Look At Kodiak AI (KDK) Valuation After A Prolonged Share Price Decline

Short term stock performance check Kodiak AI (KDK) has been on many watchlists after a weak share performance, with the stock down about 3% over the past week and about 17% over the past month. Looking further back, the stock has declined about 23% over the past 3 months and about 40% over the past year. This provides additional context for anyone tracking shorter term shifts. See our latest analysis for Kodiak AI. With the share price at $6.88 and the 1 year total shareholder return down...
NYSE:CURV
NYSE:CURVSpecialty Retail

Torrid Holdings (CURV) Posts First Quarterly Profit As Losses Challenge Bullish Turnaround Narrative

Torrid Holdings (CURV) opened Q1 2027 with total revenue of US$245.8 million, basic EPS of roughly US$0.00, net income of US$0.4 million and same store sales that fell 1.7% year over year. Over recent quarters the company has seen revenue move from US$265.97 million in Q1 2026 to US$245.8 million in Q1 2027, while basic EPS shifted from about US$0.06 in Q1 2026 to roughly US$0.00 in the latest quarter. With the trailing twelve month line still showing a loss and revenue effectively flat, this...
NYSE:BAX
NYSE:BAXMedical Equipment

Is Baxter International (BAX) Now A Potential Opportunity After Recent Share Price Rebound?

This article examines whether Baxter International at around US$19.38 is a bargain or a value trap, by breaking down what the current price could be implying about the stock. The stock has risen 3.2% over the past week and 14.1% over the past month, yet it is still down 0.6% year to date and has fallen 35.4% over the last 12 months. Recent coverage of Baxter International has focused on its role in healthcare equipment and on how investors are reassessing companies in this part of the...
NYSE:DHR
NYSE:DHRLife Sciences

Reassessing Danaher (DHR) Valuation After Mixed Share Performance And Conflicting Undervaluation Signals

Why Danaher (DHR) is Drawing Investor Attention Now Danaher (DHR) is back in focus as investors reassess the company after a mixed stretch for the stock, including a decline year to date alongside modest recent gains over the past month. See our latest analysis for Danaher. Recent trading shows a 5.36% 30 day share price return, while the year to date share price return is down 20.01% and the 5 year total shareholder return is down 13.86%. This indicates that short term momentum is improving,...
OTCPK:FGPR
OTCPK:FGPRGas Utilities

Ferrellgas Partners (OTCPK:FGPR) Profit Return Challenges Bearish Earnings Narratives

Ferrellgas Partners (OTCPK:FGPR) has just posted its Q2 2026 numbers, with revenue of US$641.4 million and basic EPS of US$2.51. The trailing twelve month figures show revenue of about US$1.9 billion and basic EPS of US$1.31, as earnings have shifted from earlier losses into profit over the past year. Over recent quarters, revenue has ranged from US$343.6 million to US$669.8 million and basic EPS has swung between a loss of US$18.83 and a profit of US$2.51. This sets up a story where margins...
NasdaqGS:ITRI
NasdaqGS:ITRIElectronic

Is Itron (ITRI) Undervalued After Recent Share Price Weakness And A US$135 Fair Value Estimate

Recent performance snapshot Itron (ITRI) has been under pressure recently, with the stock down about 3% over the past month and about 12% over the past 3 months, and the one year total return down roughly 34%. At a recent close of US$80.07 and a market cap of about US$3.6b, the company reports annual revenue of US$2.35b and net income of US$289.04m, with yearly revenue and net income growth figures provided at 5.0% and 2.6% respectively. See our latest analysis for Itron. The recent share...
NasdaqGS:EXEL
NasdaqGS:EXELBiotechs

CABINET Results Broaden CABOMETYX Neuroendocrine Reach And Investor Considerations

Exelixis reported new phase 3 CABINET trial data for CABOMETYX in advanced neuroendocrine tumors. The subgroup analysis showed significant improvements in progression free survival regardless of tumor functional status. These data were presented at ASCO 2026 and expand the evidence base for CABOMETYX in neuroendocrine tumors. For investors following NasdaqGS:EXEL, the CABINET subgroup results arrive with the stock at $52.7 and strong recent returns, including 20.9% year to date and 22.5%...
NYSE:RCUS
NYSE:RCUSBiotechs

A Look At Arcus Biosciences (RCUS) Valuation After Recent Share Price Weakness

Recent stock performance and business context Arcus Biosciences (RCUS) has drawn attention after recent share price moves, with the stock down 6.1% on the day and about 10.8% over the past month, while still up over the past 3 months. At a recent close of US$23.19 and a market value of around US$3.1b, the company remains a clinical stage cancer therapy developer with revenue of US$236.0m and a reported net loss of US$369.0m. See our latest analysis for Arcus Biosciences. Recent moves have...
NasdaqCM:SBET
NasdaqCM:SBETHospitality

Do Sharplink’s (SBET) Upgraded Earnings Estimates Reveal a Turning Point in Its Investment Narrative?

Recently, Zacks Investment Research upgraded Sharplink Inc. (SBET) to a Rank #2 (Buy), citing an upward trend in the company’s earnings estimates. This reassessment of Sharplink’s earnings outlook highlights how revisions in expectations can influence investor perception of the business’s longer-term potential. Next, we’ll explore how this improved earnings outlook, reflected in the Zacks upgrade, shapes Sharplink’s broader investment narrative. Invest in the nuclear renaissance through our...
NYSE:FDP
NYSE:FDPFood

Fresh Del Monte Produce (FDP) Valuation Check As Del Monte Foods Expands Pittsburgh Partnership And Hub Role

Fresh Del Monte Produce (FDP) is in focus after its Del Monte Foods division announced a multi-year partnership with the Pittsburgh Pirates, while also naming Pittsburgh as the operational hub for its Foods Division. See our latest analysis for Fresh Del Monte Produce. The new Pittsburgh partnership comes after a tougher stretch for the stock, with the 30 day share price return down 21.28% and the 90 day share price return down 30.70%. The three year total shareholder return sits at 21.86%,...
NasdaqGS:WBD
NasdaqGS:WBDEntertainment

Regulators Weigh Paramount Skydance Deal As WBD Streaming Turns Profitable

Paramount Skydance's acquisition of Warner Bros. Discovery (NasdaqGS:WBD) is moving through global regulatory reviews, including a formal process in Europe. U.S. attorneys general are examining potential competition and industry impacts from the proposed Hollywood combination. Warner Bros. Discovery has reported a profitable streaming segment and recorded a substantial, one off merger related fee that resulted in a large loss. Warner Bros. Discovery, the media and entertainment group behind...
NYSE:AR
NYSE:AROil and Gas

A Look At Antero Resources (AR) Valuation As Shares Trade Below Narrative Fair Value

What is moving Antero Resources stock now? Antero Resources (AR) has drawn fresh attention after recent trading, with the stock closing at US$35.56. Investors are weighing that price against the company’s reported US$5.63b in revenue and US$961.66m in net income. See our latest analysis for Antero Resources. Recent trading has been choppy, with the 1-day share price return down 4.15% and the 90-day share price return down 8.42%, even though the year-to-date share price return is up 3.95%...